InnerCool Hypothermic Neuroprotectant Clinicals To Begin In Early 2000
This article was originally published in The Gray Sheet
Executive Summary
InnerCool Therapies, Inc. will begin clinical trials for a hypothermic treatment alternative for cerebral ischemic conditions in the first half of 2000, the firm says.